View printer-friendly version << Back
MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009
FORT LAUDERDALE, Fla., Jan 26, 2009 (BUSINESS WIRE) -- MEDNAX, Inc. (NYSE:MD) will host an investor conference call and Webcast on Thursday, February 5, 2009, at 10 a.m. Eastern Time, to discuss results from operations for the three months and 12 months ended December 31, 2008. A detailed press release will be issued the morning of February 5, 2009, before the securities markets open.

The investor conference call will be Webcast and may be accessed at MEDNAX's Website,

MEDNAX, a national medical group, was recently created as a holding company that includes Pediatrix Medical Group, Inc., and American Anesthesiology, Inc.


MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,200 physicians in 32 states and Puerto Rico. Additional information is available at


MEDNAX, Inc., Fort Lauderdale Bob Kneeley, Director, Investor Relations 954-384-0175, Ext. 5300